Publications

Suppression of endothelial ceramide de novo biosynthesis by Nogo-B contributes to cardiometabolic diseases

 115
Suppression of endothelial ceramide de novo biosynthesis by Nogo-B contributes to cardiometabolic diseases

Tags:

Previous Article

ALS drug effectively treats Alzheimer’s disease

Next Article

Inhibition of ceramide synthesis contributes to cardiometabolic diseases

Related Posts

The temporal dynamics of the gut mycobiome and its association with cardiometabolic health in a nationwide cohort of 12,641 Chinese adults

The temporal dynamics of the gut mycobiome and its asso...

 98

Presynaptic α2δs specify synaptic gain, not synaptogenesis, in the mammalian brain

Presynaptic α2δs specify synaptic gain, not synaptogene...

 197

Molecular architecture of human dermal sleeping nociceptors

Molecular architecture of human dermal sleeping nocicep...

 40